Verhoeyen E - Search Results

1

Genetic in vivo engineering of human T lymphocytes in mouse models.

Weidner T, Agarwal S, Perian S, Fusil F, Braun G, Hartmann J, Verhoeyen E, Buchholz CJ. Weidner T, et al. Among authors: verhoeyen e. Nat Protoc. 2021 Jul;16(7):3210-3240. doi: 10.1038/s41596-021-00510-8. Epub 2021 Apr 12. Nat Protoc. 2021. PMID: 33846629

2

Targeted retroviral vectors displaying a cleavage site-engineered hemagglutinin (HA) through HA-protease interactions.

Szécsi J, Drury R, Josserand V, Grange MP, Boson B, Hartl I, Schneider R, Buchholz CJ, Coll JL, Russell SJ, Cosset FL, Verhoeyen E. Szécsi J, et al. Among authors: verhoeyen e. Mol Ther. 2006 Nov;14(5):735-44. doi: 10.1016/j.ymthe.2006.04.007. Epub 2006 Jun 19. Mol Ther. 2006. PMID: 16784893 Free article.

3

Lentiviral vector gene transfer into human T cells.

Verhoeyen E, Costa C, Cosset FL. Verhoeyen E, et al. Methods Mol Biol. 2009;506:97-114. doi: 10.1007/978-1-59745-409-4_8. Methods Mol Biol. 2009. PMID: 19110622

4

Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy.

Frecha C, Lévy C, Cosset FL, Verhoeyen E. Frecha C, et al. Among authors: verhoeyen e. Mol Ther. 2010 Oct;18(10):1748-57. doi: 10.1038/mt.2010.178. Epub 2010 Aug 24. Mol Ther. 2010. PMID: 20736930 Free PMC article. Review.

5

In vivo gene delivery into hCD34+ cells in a humanized mouse model.

Frecha C, Fusil F, Cosset FL, Verhoeyen E. Frecha C, et al. Among authors: verhoeyen e. Methods Mol Biol. 2011;737:367-90. doi: 10.1007/978-1-61779-095-9_15. Methods Mol Biol. 2011. PMID: 21590405

6

CD19 and CD20 targeted vectors induce minimal activation of resting B lymphocytes.

Kneissl S, Zhou Q, Schwenkert M, Cosset FL, Verhoeyen E, Buchholz CJ. Kneissl S, et al. Among authors: verhoeyen e. PLoS One. 2013 Nov 11;8(11):e79047. doi: 10.1371/journal.pone.0079047. eCollection 2013. PLoS One. 2013. PMID: 24244415 Free PMC article.

7

Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs.

Girard-Gagnepain A, Amirache F, Costa C, Lévy C, Frecha C, Fusil F, Nègre D, Lavillette D, Cosset FL, Verhoeyen E. Girard-Gagnepain A, et al. Among authors: verhoeyen e. Blood. 2014 Aug 21;124(8):1221-31. doi: 10.1182/blood-2014-02-558163. Epub 2014 Jun 20. Blood. 2014. PMID: 24951430 Free article.

8

Exclusive Transduction of Human CD4+ T Cells upon Systemic Delivery of CD4-Targeted Lentiviral Vectors.

Zhou Q, Uhlig KM, Muth A, Kimpel J, Lévy C, Münch RC, Seifried J, Pfeiffer A, Trkola A, Coulibaly C, von Laer D, Wels WS, Hartwig UF, Verhoeyen E, Buchholz CJ. Zhou Q, et al. Among authors: verhoeyen e. J Immunol. 2015 Sep 1;195(5):2493-501. doi: 10.4049/jimmunol.1500956. Epub 2015 Jul 31. J Immunol. 2015. PMID: 26232436

9

A Lentiviral Vector Allowing Physiologically Regulated Membrane-anchored and Secreted Antibody Expression Depending on B-cell Maturation Status.

Fusil F, Calattini S, Amirache F, Mancip J, Costa C, Robbins JB, Douam F, Lavillette D, Law M, Defrance T, Verhoeyen E, Cosset FL. Fusil F, et al. Among authors: verhoeyen e. Mol Ther. 2015 Nov;23(11):1734-1747. doi: 10.1038/mt.2015.148. Epub 2015 Aug 18. Mol Ther. 2015. PMID: 26281898 Free PMC article.

10

Surface engineering of lentiviral vectors for gene transfer into gene therapy target cells.

Lévy C, Verhoeyen E, Cosset FL. Lévy C, et al. Among authors: verhoeyen e. Curr Opin Pharmacol. 2015 Oct;24:79-85. doi: 10.1016/j.coph.2015.08.003. Epub 2015 Aug 25. Curr Opin Pharmacol. 2015. PMID: 26298515 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page